• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Sponsors Still Slow to Implement Electronic Innovations, Study Finds

Sponsors Still Slow to Implement Electronic Innovations, Study Finds

July 11, 2022

Despite the speed sponsors showed in adopting specific pandemic-related solutions, such as decentralized trial approaches, a new global study reveals they still face significant hurdles and long timelines when introducing broader electronic system innovations.

Implementation of new electronic solutions takes an average of 69 months from planning to enterprisewide implementation, according to a new survey report from the Tufts Center for the Study of Drug Development (CSDD).

CSDD assessed the length of time companies took on each step of the typical innovation cycle — planning/initiation, evaluation, adoption decision and full implementation — and identified issues that can contribute to slow adoption times.

The 621 respondents to the survey reported the planning and initiation stage, which takes an average of 14 months, is significantly slowed by weak support from senior management, difficulty reaching cross-functional agreement, limited encouragement to initiate and a lack of regulatory transparency. Mid-size companies took the longest on average (17.1 months), while small and large companies were faster at 11.7 and 12 months, respectively.

The 15.7-month evaluation stage, CSDD found, was marked by difficulty comparing providers, limited cross-functional coordination, poor pilot program designs and, again, limited incentive to initiate. Mid-size companies again took the longest (19.1 months on average), whereas large companies took 14.6 months and small companies took 12.1 months.

A quarter of the innovation adoption process is tied up in deciding whether to move forward with a full implementation, the study found, taking sponsors 16.9 months on average overall, with mid-size sponsors the slowest once again (19.3 months). Large companies also moved slowly through this step (16.6 months), while smaller companies were faster (12.9 months).

The longest phase of adoption, by far, is full implementation, which took sponsors almost two years to complete. Here, large and mid-size companies saw similar times (23.4 and 23.7 months, respectively), while smaller companies moved a bit faster (20.7 months). Companies named weak senior management support, a lack of continuity in adoption investment, weak change management planning and a lack of alignment on incentives as the key sources of delays and inefficiencies.

Access the full CSDD report here: https://bit.ly/3RjRFpO.

The CenterWatch Monthly will provide a more in-depth analysis of this topic in its August 2022 issue. For information, go to https://bit.ly/3nRVBAA.

 

To view more CenterWatch Weekly stories, click here.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing